Novacyt S.A.
Novacyt S.A. NCYT.L Peers
See (NCYT.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NCYT.L | $39.05 | -3.46% | 27.58M | -0.71 | -$0.55 | N/A |
| 0A0L.IL | $311.40 | -2.93% | 60.08B | 156.48 | $1.99 | +0.35% |
| 0GZV.IL | $188.38 | -2.41% | 51.21B | 23.78 | $7.92 | +2.44% |
| 0YAY.L | $299.20 | -0.60% | 21.34B | N/A | N/A | +0.74% |
| 0QPY.L | $337.10 | +0.09% | 16.85B | 32.57 | $10.35 | +1.60% |
| SN.L | $1,061.00 | -1.76% | 9.28B | 30.31 | $0.35 | +3.00% |
| MGP.L | $212.00 | +0.47% | 268.14M | 35.33 | $0.06 | N/A |
| MXCT.L | $165.00 | -2.94% | 175.43M | -5.50 | -$0.30 | N/A |
| EKF.L | $27.00 | +3.45% | 121.26M | 27.00 | $0.01 | N/A |
| CREO.L | $12.00 | +9.09% | 45.67M | -1.50 | -$0.08 | N/A |
Stock Comparison
NCYT.L vs 0A0L.IL Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, 0A0L.IL has a market cap of 60.08B. Regarding current trading prices, NCYT.L is priced at $39.05, while 0A0L.IL trades at $311.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas 0A0L.IL's P/E ratio is 156.48. In terms of profitability, NCYT.L's ROE is -0.48%, compared to 0A0L.IL's ROE of +0.36%. Regarding short-term risk, NCYT.L is more volatile compared to 0A0L.IL. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs 0GZV.IL Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, 0GZV.IL has a market cap of 51.21B. Regarding current trading prices, NCYT.L is priced at $39.05, while 0GZV.IL trades at $188.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas 0GZV.IL's P/E ratio is 23.78. In terms of profitability, NCYT.L's ROE is -0.48%, compared to 0GZV.IL's ROE of +0.05%. Regarding short-term risk, NCYT.L is more volatile compared to 0GZV.IL. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs 0YAY.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, 0YAY.L has a market cap of 21.34B. Regarding current trading prices, NCYT.L is priced at $39.05, while 0YAY.L trades at $299.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas 0YAY.L's P/E ratio is N/A. In terms of profitability, NCYT.L's ROE is -0.48%, compared to 0YAY.L's ROE of +0.04%. Regarding short-term risk, NCYT.L is more volatile compared to 0YAY.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs 0QPY.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, 0QPY.L has a market cap of 16.85B. Regarding current trading prices, NCYT.L is priced at $39.05, while 0QPY.L trades at $337.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas 0QPY.L's P/E ratio is 32.57. In terms of profitability, NCYT.L's ROE is -0.48%, compared to 0QPY.L's ROE of +0.23%. Regarding short-term risk, NCYT.L is more volatile compared to 0QPY.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs SN.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, SN.L has a market cap of 9.28B. Regarding current trading prices, NCYT.L is priced at $39.05, while SN.L trades at $1,061.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas SN.L's P/E ratio is 30.31. In terms of profitability, NCYT.L's ROE is -0.48%, compared to SN.L's ROE of +0.05%. Regarding short-term risk, NCYT.L is more volatile compared to SN.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs MGP.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, MGP.L has a market cap of 268.14M. Regarding current trading prices, NCYT.L is priced at $39.05, while MGP.L trades at $212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas MGP.L's P/E ratio is 35.33. In terms of profitability, NCYT.L's ROE is -0.48%, compared to MGP.L's ROE of +0.12%. Regarding short-term risk, NCYT.L is more volatile compared to MGP.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs MXCT.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, MXCT.L has a market cap of 175.43M. Regarding current trading prices, NCYT.L is priced at $39.05, while MXCT.L trades at $165.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas MXCT.L's P/E ratio is -5.50. In terms of profitability, NCYT.L's ROE is -0.48%, compared to MXCT.L's ROE of -0.19%. Regarding short-term risk, NCYT.L is more volatile compared to MXCT.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs EKF.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, EKF.L has a market cap of 121.26M. Regarding current trading prices, NCYT.L is priced at $39.05, while EKF.L trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas EKF.L's P/E ratio is 27.00. In terms of profitability, NCYT.L's ROE is -0.48%, compared to EKF.L's ROE of +0.09%. Regarding short-term risk, NCYT.L is more volatile compared to EKF.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs CREO.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, CREO.L has a market cap of 45.67M. Regarding current trading prices, NCYT.L is priced at $39.05, while CREO.L trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas CREO.L's P/E ratio is -1.50. In terms of profitability, NCYT.L's ROE is -0.48%, compared to CREO.L's ROE of -0.42%. Regarding short-term risk, NCYT.L is less volatile compared to CREO.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs IUG.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, IUG.L has a market cap of 42.62M. Regarding current trading prices, NCYT.L is priced at $39.05, while IUG.L trades at $12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas IUG.L's P/E ratio is -12.87. In terms of profitability, NCYT.L's ROE is -0.48%, compared to IUG.L's ROE of -0.38%. Regarding short-term risk, NCYT.L is more volatile compared to IUG.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs 0QMX.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, 0QMX.L has a market cap of 33.60M. Regarding current trading prices, NCYT.L is priced at $39.05, while 0QMX.L trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas 0QMX.L's P/E ratio is -4.25. In terms of profitability, NCYT.L's ROE is -0.48%, compared to 0QMX.L's ROE of -0.09%. Regarding short-term risk, NCYT.L is more volatile compared to 0QMX.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs IHC.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, IHC.L has a market cap of 17.48M. Regarding current trading prices, NCYT.L is priced at $39.05, while IHC.L trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas IHC.L's P/E ratio is -1.39. In terms of profitability, NCYT.L's ROE is -0.48%, compared to IHC.L's ROE of -0.34%. Regarding short-term risk, NCYT.L is less volatile compared to IHC.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs POLX.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, POLX.L has a market cap of 14.18M. Regarding current trading prices, NCYT.L is priced at $39.05, while POLX.L trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas POLX.L's P/E ratio is -1.17. In terms of profitability, NCYT.L's ROE is -0.48%, compared to POLX.L's ROE of -0.86%. Regarding short-term risk, NCYT.L is less volatile compared to POLX.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs AVO.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, AVO.L has a market cap of 9.50M. Regarding current trading prices, NCYT.L is priced at $39.05, while AVO.L trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas AVO.L's P/E ratio is -0.25. In terms of profitability, NCYT.L's ROE is -0.48%, compared to AVO.L's ROE of +0.00%. Regarding short-term risk, NCYT.L is more volatile compared to AVO.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs RUA.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, RUA.L has a market cap of 7.14M. Regarding current trading prices, NCYT.L is priced at $39.05, while RUA.L trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas RUA.L's P/E ratio is 11.50. In terms of profitability, NCYT.L's ROE is -0.48%, compared to RUA.L's ROE of +0.03%. Regarding short-term risk, NCYT.L is more volatile compared to RUA.L. This indicates potentially higher risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs SUN.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, SUN.L has a market cap of 6.30M. Regarding current trading prices, NCYT.L is priced at $39.05, while SUN.L trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas SUN.L's P/E ratio is N/A. In terms of profitability, NCYT.L's ROE is -0.48%, compared to SUN.L's ROE of -0.06%. Regarding short-term risk, NCYT.L is less volatile compared to SUN.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs MHC.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, MHC.L has a market cap of 6.11M. Regarding current trading prices, NCYT.L is priced at $39.05, while MHC.L trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas MHC.L's P/E ratio is -5.87. In terms of profitability, NCYT.L's ROE is -0.48%, compared to MHC.L's ROE of -0.13%. Regarding short-term risk, NCYT.L is less volatile compared to MHC.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs BELL.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, BELL.L has a market cap of 3.41M. Regarding current trading prices, NCYT.L is priced at $39.05, while BELL.L trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas BELL.L's P/E ratio is -0.08. In terms of profitability, NCYT.L's ROE is -0.48%, compared to BELL.L's ROE of -1.03%. Regarding short-term risk, NCYT.L is less volatile compared to BELL.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.
NCYT.L vs DEMG.L Comparison
NCYT.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCYT.L stands at 27.58M. In comparison, DEMG.L has a market cap of 663609.00. Regarding current trading prices, NCYT.L is priced at $39.05, while DEMG.L trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCYT.L currently has a P/E ratio of -0.71, whereas DEMG.L's P/E ratio is N/A. In terms of profitability, NCYT.L's ROE is -0.48%, compared to DEMG.L's ROE of -0.42%. Regarding short-term risk, NCYT.L is less volatile compared to DEMG.L. This indicates potentially lower risk in terms of short-term price fluctuations for NCYT.L.